Understanding New Healthcare Buyers

Leah Hoffmann

A medical device manufacturer had just launched a product that dramatically cut patient recovery time—as well as recovery-related expenses. Could the company accelerate sales by working with healthcare payers and IDNs, rather than physicians?

Business Talent Group assembled a tight two-person team of healthcare experts. One was a senior consultant and previous lead of McKinsey’s life science practice. She was joined by an experienced health economist with a strong network in the payer space. Together, our team interviewed payer representatives, refined value propositions, and provided a topline estimate of the opportunity’s magnitude.

After analyzing market attractiveness and reimbursement options, the consultants concluded that profit margins were too slim for the new buyer group.

 

Previous Article
Mission-Critical Program Management
Mission-Critical Program Management

A vertically integrated Managed Care Organization faced a rigorous re-certification that was straining the ...

Next Article
Rethinking Health Analytics Strategies
Rethinking Health Analytics Strategies

A global biopharma company was struggling to manage its growing pipeline of health analytics initiatives. H...

Do you know the top talent trends in healthcare and life sciences this year?

Get the Report